GMT | ||||
---|---|---|---|---|
Before immunisation | After immunisation | |||
N | Value (95% CI) | Factor increase in GMT | ||
ARD | 1668 | 8.0 (7.7 to 8.4)* | 71.5 (66.2 to 77.3)* | 8.9 (8.3 to 9.6)* |
SLE | 572 | 7.5 (7.0 to 8.0)* | 59.2 (51.9 to 67.4)* | 7.9 (7.0 to 8.9)* |
RA | 343 | 8.0 (7.3 to 8.8) | 57.7 (48.1 to 69.1)* | 7.2 (6.1 to 8.5)* |
PsA | 101 | 8.5 (7.1 to 10.1) | 56.0 (40.2 to 77.9)* | 6.6 (4.9 to 8.9)* |
AS | 152 | 7.9 (6.9 to 8.9) | 80.0 (62.8 to 101.9)* | 10.2 (8.1 to 12.8) |
BD | 85 | 7.2 (6.0 to 8.6) | 95.7 (68.2 to 134.3) | 13.4 (9.8 to 18.2) |
DM | 45 | 7.5 (6.0 to 9.2) | 83.8 (48.3 to 145.5) | 11.2 (6.8 to 18.6) |
SSc | 127 | 11.2 (9.2 to 13.7) | 134.4 (101.4 to 178) | 12.0 (9.1 to 15.8) |
MCTD | 69 | 8.3 (6.8 to 10.3) | 83.3 (59.0 to 117.6) | 10.0 (7.0 to 14.2) |
PAPS | 54 | 6.5 (5.5 to 7.5) | 83.4 (57.8 to 120.4) | 12.9 (9.0 to 18.6) |
pSS | 36 | 8.9 (6.4 to 12.4) | 95.1 (59.4 to 152.3) | 10.7 (6.6 to 17.2) |
TA | 30 | 8.5 (6.1 to 11.8) | 179.6 (102.1 to 316.0) | 21.1 (11.7 to 38.1) |
PM | 28 | 11.3 (7.6 to 16.9) | 148.5 (86.2 to 256) | 13.1 (7.9 to 21.9) |
WG | 26 | 9.2 (5.9 to 14.4) | 73.9 (42.1 to 129.5) | 8 (5.0 to 12.7) |
Control | 234 | 9.3 (8.2 to 10.5) | 122.9 (103.4 to 146.1) | 13.2 (11.1 to 15.8) |
Data are expressed in value (95% CI).
↵* p<0.05.
ARD, autoimmune rheumatic diseases; AS, ankylosing spondylitis; BD, Behçet's disease; DM, dermatomyositis; GMT, geometric mean titre; MCTD, mixed connective tissue disease; PAPS, primary antiphospholipid syndrome; PM, polymyositis; PsA, psoriatic arthritis; pSS, primary Sjögren's syndrome; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSc, systemic sclerosis; TA, Takayasu's arteritis; WG, Wegener's granulomatosis.